| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 7 |
| 1 | BORTEZOMIB | 4 |
| 2 | CARFILZOMIB | 4 |
| 3 | CYCLOPHOSPHAMIDE | 4 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 4 |
| 6 | DARATUMUMAB | 4 |
| 7 | LENALIDOMIDE | 4 |
| 8 | POMALIDOMIDE | 4 |
| 9 | ZOLEDRONIC ACID | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ECHOTHIOPHATE IODIDE FOR OPHTHALMIC SOLUTION | 1 | 0.0068 |
| 1 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION | 1 | 0.0013 |
| 2 | ACETAZOLAMIDE SODIUM | 1 | 0.0002 |
| 3 | CARFILZOMIB | 4 | 0.0001 |
| 4 | TIMOLOL MALEATE OPHTHALMIC | 1 | 0.0001 |
| 5 | DORZOLAMIDE | 1 | 0.0001 |
| 6 | TIMOLOL MALEATE | 1 | 0.0001 |
| 7 | ZOLEDRONIC ACID | 4 | 0.0001 |
| 8 | ASFOTASE ALFA | 1 | 0.0001 |
| 9 | OXALIPLATIN | 7 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 1 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 2 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 3 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Proteasome Inhibitor [EPC] | 4 | 0.0000 |
| 5 | Prostaglandin Analog [EPC] | 3 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 7 | 0.0000 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 4 | 0.0000 |
| 9 | Thalidomide Analog [EPC] | 4 | 0.0000 |